SCHEMBL20311508

SCHEMBL20311508

O=C(OCc1ccccc1)c1ccc2nsnc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.63
▸ MAPT P10636 5/20 0.63
▸ KMT2A Q03164 5/20 0.63
▸ MEN1 O00255 2/20 0.63
▸ TDP1 Q9NUW8 4/20 0.57
▸ SLC6A2 P23975 1/20 0.57
▸ SLC6A3 Q01959 1/20 0.57
▸ LMNA P02545 4/20 0.56
▸ RAB9A P51151 7/20 0.53
▸ NPC1 O15118 5/20 0.53
▸ SMN1; SMN2 Q16637 5/20 0.53
▸ HPGD P15428 2/20 0.52
▸ POLB P06746 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ GAA P10253 1/20 0.46
▸ HTT P42858 1/20 0.45
▸ JMJD6 Q6NYC1 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22807551 0.84 ALDH1A1 (0.57) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL2244369 0.81 KMT2A (0.58) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL312287 0.78 KMT2A (0.92) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL21240899 0.77 KDM4E (0.64) ALDH1A1MAPTKMT2ATDP1SLC6A2
SCHEMBL6002245 0.77 KMT2A (0.70) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL312910 0.76 TDP1 (0.81) ALDH1A1MAPTKMT2ATDP1SLC6A2
SCHEMBL25409845 0.76 TDP1 (0.55) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL6282770 0.76 KMT2A (0.81) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL25407262 0.75 TDP1 (0.54) ALDH1A1MAPTKMT2ATDP1SLC6A2
SCHEMBL4982062 0.75 ALOX15 (0.62) ALDH1A1MAPTKMT2ATDP1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873031-B2 P-doped conjugated small molecular electrolyte and organic electronic devices using the same GWANGJU INSTITUTE OE SCIENCE AND TECHNOLOGY (KR) 2020-12-22 — — US disclosed
EP-2802576-B1 HETEROCYCLIC-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10873031-B2 P-doped conjugated small molecular electrolyte and organic electronic devices using the same EMG1, KCNN2, MRPS22 ALDH1A1 765/4885MAPT 2347/4885KMT2A 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback